Comerica Bank
MRVI icon

Comerica Bank’s Maravai LifeSciences MRVI Stock Holding History

Comerica Bank’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$9.12K Buy
2,806
+296
+12% +$997 ﹤0.01% 3268
2025
Q3 		$7.2K Sell
2,510
-27
-1% -$69 ﹤0.01% 3330
2025
Q2 		$6.11K Buy
2,537
+470
+23% +$988 ﹤0.01% 3330
2025
Q1 		$4.57K Sell
2,067
-92
-4% -$364 ﹤0.01% 3336
2024
Q4 		$11.8K Sell
2,159
-1,260
-37% -$8.11K ﹤0.01% 3149
2024
Q3 		$28.4K Buy
3,419
+1,353
+65% +$11.7K ﹤0.01% 2937
2024
Q2 		$14.8K Sell
2,066
-3
-0.1% -$26 ﹤0.01% 3072
2024
Q1 		$17.9K Sell
2,069
-427
-17% -$2.89K ﹤0.01% 3053
2023
Q4 		$16.3K Sell
2,496
-463
-16% -$2.99K ﹤0.01% 3019
2023
Q3 		$29.6K Buy
2,959
+1,523
+106% +$16.7K ﹤0.01% 2873
2023
Q2 		$6 Buy
+1,436
New +$19.4K ﹤0.01% 439

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Comerica Bank's MRVI Position: Q4 2025 in Review

Comerica Bank increased its Maravai LifeSciences (MRVI) stake by 12% in Q4 2025, buying an estimated $997 and bringing the position to 2,806 shares worth $9.12K. The position accounts for ﹤0.01% of the portfolio, ranked #3268.

Comerica Bank first reported a position in MRVI in Q2 2023 and has held it in 11 quarters since. The position peaked at $29.6K in Q3 2023. 159 funds tracked by Wall St. Rank hold MRVI as of Q4 2025.

  • Comerica Bank held 2,806 shares of Maravai LifeSciences worth $9.12K as of Q4 2025.
  • Comerica Bank bought 296 Maravai LifeSciences shares in Q4 2025, an estimated $997.
  • Maravai LifeSciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3268 holding.
  • Comerica Bank first reported a position in Maravai LifeSciences in Q2 2023 and has held it in 11 quarters since.
  • Comerica Bank's Maravai LifeSciences position peaked at $29.6K in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.